Jane Street Group, LLC Bellus Health Inc. Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.14 - $8.53 $222,939 - $266,340	-31,224 Reduced 54.53%	26,039 $187,000
Q4 2022 Feb 14, 2023	BUY	$8.22 - $10.76 $214,689 - $281,029	26,118 Added 83.86%	57,263 $470,000
Q3 2022 Nov 14, 2022	SELL	$8.95 - $12.0 $589,447 - $790,320	-65,860 Reduced 67.89%	31,145 $328,000
Q3 2022 Nov 14, 2022	SELL	$8.95 - $12.0 $589,447 - $790,320	-65,860 Reduced 67.89%	31,145 $328,000
Q2 2022 Aug 16, 2022	BUY	$6.46 - $10.02 $518,944 - $804,926	80,332 Added 481.81%	97,005 $893,000
Q4 2021 Feb 15, 2022	SELL	$5.26 - $8.3 $109,813 - $173,279	-20,877 Reduced 55.6%	16,673 $134,000
Q3 2021 Nov 16, 2021	BUY	$2.7 - $6.64 $101,385 - $249,332	37,550 New	37,550 $229,000
Q1 2021 May 18, 2021	SELL	$3.03 - $4.58 $98,384 - $148,712	-32,470 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$2.27 - $3.3 $73,706 - $107,151	32,470 New	32,470 $98,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.